<i>Efficacy of Danlou Tablet</i> in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial

<div>Survival curves. Kaplan-Meier curves of 90-day major adverse cardiac event- (MACE-) free survival in the 2 arms. MACE, major adverse cardiac event (death, nonfatal myocardial infarction, target vessel revascularisation, and rehospitalization due to acute cardiovascular events).</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: <i>Efficacy of Danlou Tablet</i> in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial 

Figure 3 | Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial 